REVSIRIO Trademark

Trademark Overview


On Tuesday, February 26, 2019, a trademark application was filed for REVSIRIO with the United States Patent and Trademark Office. The USPTO has given the REVSIRIO trademark a serial number of 88316871. The federal status of this trademark filing is REGISTERED as of Tuesday, February 18, 2020. This trademark is owned by Santen Pharmaceutical Co., Ltd.. The REVSIRIO trademark is filed in the Pharmaceutical Products category with the following description:

Collyrium; eye drops; ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for the treatment of eye diseases and conditions; pharmaceutical preparations for use in eye injections for the treatment of eye diseases and conditions; pharmaceutical preparations for treatment of pinguecula; pharmaceutical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; pharmaceutical preparations for improving focus-adjustment function declined by accommodative asthenopia; pharmaceutical preparations for treatment of accommodative asthenopia; eye drops for treatment of keratoconjunctival epithelial disorder; antibacterial eye drops; antiallergic eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions; dietetic foods adapted for medical purposes; dietetic bev...
revsirio

General Information


Serial Number88316871
Word MarkREVSIRIO
Filing DateTuesday, February 26, 2019
Status700 - REGISTERED
Status DateTuesday, February 18, 2020
Registration Number5988008
Registration DateTuesday, February 18, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2019

Trademark Statements


Goods and ServicesCollyrium; eye drops; ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for the treatment of eye diseases and conditions; pharmaceutical preparations for use in eye injections for the treatment of eye diseases and conditions; pharmaceutical preparations for treatment of pinguecula; pharmaceutical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; pharmaceutical preparations for improving focus-adjustment function declined by accommodative asthenopia; pharmaceutical preparations for treatment of accommodative asthenopia; eye drops for treatment of keratoconjunctival epithelial disorder; antibacterial eye drops; antiallergic eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for medical use; capsules for medicines, namely, capsules sold empty for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters, namely, adhesive plasters for medical purposes, sticking plasters for medical purposes and medical and surgical plasters; bandages for dressings; liquid bandages, namely, antiseptic liquid bandages, liquid bandage sprays and liquid bandages for skin wounds; breast-nursing pads; dental materials, namely, dental cements, materials for dental fillings and dental prostheses, dental waxes; diapers for incontinence; lactose for pharmaceutical purposes
Translation of Words in MarkThe wording "REVSIRIO" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 18, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanten Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka 530-8552
JP

Party NameSanten Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka 533-8651
JP

Party NameSanten Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka 533-8651
JP

Trademark Events


Event DateEvent Description
Wednesday, March 18, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 18, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 18, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 18, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 18, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 18, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, December 3, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 28, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 28, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 28, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 21, 2019ASSIGNED TO LIE
Tuesday, October 15, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 14, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 14, 2019NON-FINAL ACTION E-MAILED
Tuesday, May 14, 2019NON-FINAL ACTION WRITTEN
Tuesday, May 7, 2019ASSIGNED TO EXAMINER
Monday, March 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 1, 2019NEW APPLICATION ENTERED IN TRAM